Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 14, 2010 CD
Six back issues from 2010 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 14 No. 1 January/February 2010 Pediatrics and Wellness
Vol. 14 No. 2 March/April 2010 Compounding for Men
Vol. 14 No. 3 May/June 2010 Pain Management
Vol. 14 No. 4 July/August 2010 Sterile Compounding
Vol. 14 No. 5 September/October 2010 Supporting Quality Pharmaceutical Compounding World Wide
Vol. 14 No. 6 November/December 2010 Volume 14, Number 6

Volume 14, 2010 CD ARTICLES

Volume14, 2010 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: APhA and IJPC Working Together Vol. 14 No. 1 4
PreScription: American Pharmacists Assocation and Compounding: New Partnership Reflects Old Ties Vol. 14 No. 1 4
When Traditional Medicine Fails Vol. 14 No. 1 6
Sleepless in America: Compounding with Melatonin Vol. 14 No. 1 10
Prophylaxis Against Exposure to Bloodborne Pathogens During Compounding Vol. 14 No. 1 14
Compounding Pharmacy: A Unique Service for a Unique Population Vol. 14 No. 1 19
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Vol. 14 No. 1 21
Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging Vol. 14 No. 1 26
Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting Vol. 14 No. 1 32
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Vol. 14 No. 1 40
An Academic Practice Partnership: An Innovative Course in Advanced Compounding Vol. 14 No. 1 48
Literature Review & Importance of Quality Control Vol. 14 No. 1 54
Calculations Vol. 14 No. 1 58
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control Vol. 14 No. 1 60
Hand Sanitizer Gel Vol. 14 No. 1 66
Hydrocarbon-Free Lotion Vol. 14 No. 1 67
Ketoprofen 100-mg/5-mL Mouth Rinse Vol. 14 No. 1 68
Metronidazole in Normal Saline Enema Vol. 14 No. 1 69
Ophthalmic Toning-Lubricating Drops Vol. 14 No. 1 70
Solprotex 2.5% Lotion Vol. 14 No. 1 71
Testosterone 1% in Alcoholic Gel Vol. 14 No. 1 72
Tetracaine 4% and Menthol 5% Topical Gel Vol. 14 No. 1 73
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Vol. 14 No. 1 74
Trigger Point Gel Vol. 14 No. 1 75
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle Vol. 14 No. 1 76
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam Vol. 14 No. 1 78
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Vol. 14 No. 1 82
Postscription: 2010 A New Year, New Commitments, and New Challenges Vol. 14 No. 1 86
PreScription: The Ages of Man Vol. 14 No. 2 92
PreScription: Changing the Game Vol. 14 No. 2 92
Emerging Evidence for Androgen Replacement Therapy in Aging Men Vol. 14 No. 2 94
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject Vol. 14 No. 2 100
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword? Vol. 14 No. 2 105
Coenzyme Q10 Supplementation in the Treatment of Heart Disease Vol. 14 No. 2 108
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient Vol. 14 No. 2 112
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Vol. 14 No. 2 118
Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes Vol. 14 No. 2 124
Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs Vol. 14 No. 2 131
Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network Vol. 14 No. 2 134
Quality Control: From Record Keeping to Key Performance Indicators: Managing Quality in Compounding Pharmacies Vol. 14 No. 2 136
Calculations Vol. 14 No. 2 140
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests Vol. 14 No. 2 142
Acyclovir 5% in Oral Adhesive Paste Vol. 14 No. 2 150
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) Vol. 14 No. 2 151
Ciclopirox 10% in Isopropyl Alcohol Nail Solution Vol. 14 No. 2 152
Clotrimazole 1% Oral Adhesive Paste Vol. 14 No. 2 153
Cyclosporin 10-mg/g in Oral Adhesive Paste Vol. 14 No. 2 154
Dexpanthenol 5% Gel-Cream Vol. 14 No. 2 155
Lamotrigine 25-mg/mL Injection Vol. 14 No. 2 156
Metolazone 10-mg/mL Injection Vol. 14 No. 2 157
Plasticized Hydrocarbon Gel Vol. 14 No. 2 158
Oral Adhesive Paste Vol. 14 No. 2 159
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Vol. 14 No. 2 160
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study Vol. 14 No. 2 165
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Vol. 14 No. 2 171
PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort? Vol. 14 No. 2 174
PreScription: Quality Improvement in Pharmaceutical Compounding Vol. 14 No. 3 180
PreScription: Healthcare Reform Is Not All That Is Happening in Washington Vol. 14 No. 3 180
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Vol. 14 No. 3 182
The Role of Sex Hormones on Fibromyalgia Pain Mediators Vol. 14 No. 3 193
Topical Medications for Orofacial Neuropathic Pain Vol. 14 No. 3 200
Managing Pain with Transdermal Ketoprofen Vol. 14 No. 3 204
Potential Treatments for Radiation Dermatitis Vol. 14 No. 3 210
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report Vol. 14 No. 3 215
Quality Control Analytical Methods: Continuous Quality Improvement Vol. 14 No. 3 218
Basics of Compounding: Compounding with Hydrates and Solvates Vol. 14 No. 3 222
Calculations Vol. 14 No. 3 230
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Vol. 14 No. 3 232
Bacitracin 10,000-Units/mL Ophthalmic Solution Vol. 14 No. 3 240
Carprofen 2.5-mg/mL Oral Suspension, Veterinary Vol. 14 No. 3 241
Celecoxib 10-mg/mL Oral Suspension Vol. 14 No. 3 242
Clozapine 20-mg/mL Oral Suspension Vol. 14 No. 3 243
Cohen's Rectal Ointment Vol. 14 No. 3 244
Cyclophosphamide 10-mg/mL Oral Suspension Vol. 14 No. 3 245
Lansoprazole 3-mg/mL Oral Suspension Vol. 14 No. 3 246
Rifaximin 20-mg/mL Oral Suspension Vol. 14 No. 3 247
Sunitinib 10-mg/mL Oral Suspension Vol. 14 No. 3 248
Voriconazole 40-mg/mL Oral Suspension, Veterinary Vol. 14 No. 3 249
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration Vol. 14 No. 3 250
Weight Uniformity of Scored Tablet Halves Manufactured by Palestinian Pharmaceutical Companies Vol. 14 No. 3 257
PostScription: Healthcare Reform and Compounding Issues Vol. 14 No. 3 262
PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle Vol. 14 No. 4 268
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals Vol. 14 No. 4 268
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Vol. 14 No. 4 270
Recommendations for Compounding Medications for Feeding Tube Administration Vol. 14 No. 4 276
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents Vol. 14 No. 4 284
Considerations for Percutaneous Absorption Vol. 14 No. 4 301
Thyroid Potency Calculations Vol. 14 No. 4 306
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Vol. 14 No. 4 310
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters Vol. 14 No. 4 317
Basics of Compounding: Basics of Compounding with Organic Salts Vol. 14 No. 4 322
Calculations Vol. 14 No. 4 327
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Vol. 14 No. 4 328
Acyclovir with Benzocaine Lip Balm Vol. 14 No. 4 332
Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone Vol. 14 No. 4 333
Amitriptyline Hydrochloride Suppositories Vol. 14 No. 4 334
Ampicillin 250-mg Suppository Vol. 14 No. 4 335
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops Vol. 14 No. 4 336
Buprenorphine Hydrochloride Injection Vol. 14 No. 4 337
Chloroprocaine Hydrochloride Injection Vol. 14 No. 4 338
Cyanocobalamin, Choline, and Niacinamide Injection Vol. 14 No. 4 339
Fenoldopam Mesylate Injection Vol. 14 No. 4 340
Flurbiprofen 5% Bioadhesive Gel for Gingivitis Vol. 14 No. 4 341
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Vol. 14 No. 4 342
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Vol. 14 No. 4 346
PostScription: Innovative Community Pharmacy Practice: Past, Present, and Future Vol. 14 No. 4 350
PreScription: Revised Format Vol. 14 No. 5 358
PreScription: Compounding Veterinary Products: Needed but Problematic Vol. 14 No. 5 358
Home Infusion Accreditation: Another Quality Recognition Branding Tool Vol. 14 No. 5 360
Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response Vol. 14 No. 5 366
Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device Vol. 14 No. 5 370
Bioidentical Hormones in the News Vol. 14 No. 5 374
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists Vol. 14 No. 5 382
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Vol. 14 No. 5 395
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 1 Vol. 14 No. 5 401
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 Vol. 14 No. 5 407
Basics of Compounding: Basics of Compounding with Esters Vol. 14 No. 5 416
Calculations Vol. 14 No. 5 419
Alpha-Bisabolol Mouthwash Vol. 14 No. 5 420
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Vol. 14 No. 5 421
Icy Blue Camphorated Gel Vol. 14 No. 5 422
Carvedilol 1-mg/mL Oral Suspension Vol. 14 No. 5 423
Buspirone 2.5-mg/mL Oral Suspension Vol. 14 No. 5 424
Triclosan 0.28% Mouthwash Vol. 14 No. 5 425
Rufinamide 40-mg/mL Oral Suspension Vol. 14 No. 5 426
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Vol. 14 No. 5 427
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Vol. 14 No. 5 428
Polidocanol 0.5% Wound Spray Vol. 14 No. 5 429
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Vol. 14 No. 5 430
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Vol. 14 No. 5 436
PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board Vol. 14 No. 5 440
PreScription: Compounding with Manufactured Products Vol. 14 No. 6 448
Home Infusion: Overcoming the Barriers to Entry Vol. 14 No. 6 450
In the Hands of Your Enemy Vol. 14 No. 6 456
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women Vol. 14 No. 6 465
Extemporaneous Compounding of Medicated Ointment Vol. 14 No. 6 472
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care Vol. 14 No. 6 480
All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding Vol. 14 No. 6 484
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Vol. 14 No. 6 488
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2 Vol. 14 No. 6 493
Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates Vol. 14 No. 6 508
Calculations Vol. 14 No. 6 511
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Vol. 14 No. 6 512
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Vol. 14 No. 6 513
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Vol. 14 No. 6 514
Bromazepam 2.5-mg/mL Drops Vol. 14 No. 6 515
Bromhexine Hydrochloride 0.8-mg/mL Syrup Vol. 14 No. 6 516
Capsaicin 0.05% Clear Medication Stick Vol. 14 No. 6 517
Glutathione 25% in Pluronic Lecithin Organogel Vol. 14 No. 6 518
Gramicidin 13% Ophthalmic Solution Vol. 14 No. 6 519
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Vol. 14 No. 6 520
Ketoprofen 2% Oral Gel Vol. 14 No. 6 521
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Vol. 14 No. 6 522
Barrier Isolator/Glovebox Glove Dexterity Study Vol. 14 No. 6 526
PostScription: Profile of a Pharmacy Compounding Accreditation Board Accredited Pharmacy: Avera Doctors Plaza 2 Pharmacy Vol. 14 No. 6 531